<?xml version="1.0" encoding="UTF-8"?>
<p id="p0130">For instance, 
 <italic>Aristolochia albida</italic> Duch (0.2 RFC) has been prescribed for cancer treatment. While a species of 
 <italic>Aristolochia</italic> have been documented in a similar study (
 <xref rid="bib142" ref-type="bibr">Ngulde et al., 2014</xref>), its toxic side effects have yet to be established. Generally, 
 <italic>Aristolochia</italic> and one of its chief components aristolochic acid have been known for its carcinogenic, and nephrotoxic effects for a very long time (
 <xref rid="bib125" ref-type="bibr">Michael et al., 2009</xref>). Recently, several toxicological risks associated with a history of using herbal medicines containing aristolochic acid amongst cancer patients have been reported (
 <xref rid="bib29" ref-type="bibr">Aydin et al., 2017</xref>; 
 <xref rid="bib32" ref-type="bibr">Ban et al., 2018</xref>; 
 <xref rid="bib45" ref-type="bibr">Chen et al., 2018</xref>; 
 <xref rid="bib81" ref-type="bibr">Hoang et al., 2016</xref>; 
 <xref rid="bib83" ref-type="bibr">Hung et al., 2016</xref>; 
 <xref rid="bib93" ref-type="bibr">Kanaan et al., 2016</xref>; 
 <xref rid="bib159" ref-type="bibr">Popovska-Jankovic et al., 2016</xref>; 
 <xref rid="bib201" ref-type="bibr">Xiong et al., 2018</xref>; 
 <xref rid="bib210" ref-type="bibr">Zhong et al., 2017</xref>). Despite the reported cases on the use of herbs containing aristolochic acid around the world, a similar effect associated with the use of 
 <italic>Aristolochia</italic> spp has yet to be reported in Nigeria.
</p>
